360.1 Long-term kidney transplant recipients exhibit a dominance of T-lymphocyte subpopulations with an immunosenescent phenotype
Dr. Asimina Fylaktou, Greece
360.2 Intercontinental insights: registry based comparisons of pregnancy post-kidney transplantation
Miss Styliani Giapoutzidou, Netherlands
360.3 Predicting Long-Term Outcomes in Living Kidney Donor Transplant Recipients Using Deep Learning Algorithm-Estimated Medullary Pyramid Count: A Novel Biomarker
Dr. Samy Riad, United States
360.4
Impact of type 2 diabetes and obesity on contemporary adult living donor kidney transplant outcomes – a national cohort study
Dr. Vinayak S Rohan, United States
360.5 Pre-transplant residual diuresis and oxalic acid concentration significantly and independently influence kidney graft survival
Gideon Post Hospers, Netherlands
360.6 A mate-kidney analysis examining the impact of Delayed Graft Function on kidney survival; implications for the clinician and clinical trial design
Dr. Ross Doyle, Ireland
360.7 Retransplant potential and repeat transplant outcome in patients with failed allografts attributed to recurrent glomerulonephritis
Wai Lim, Australia
360.8 Repeat HLA Class II but not Class I mismatches are associated with increased loss of second kidney grafts: a contemporary Collaborative Transplant Study (CTS) analysis
Prof. Karl M Wissing, Belgium
360.9 Proton pump inhibitors worsen patient and allograft survival in kidney transplant recipients : a time-dependent cohort analysis